| USD millions | FY2024 | FY2025 | TTM |
|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 |
| Cost of revenue | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 |
| Research & development | 0.0 | 0.0 | — |
| Selling, general & administrative | 0.0 | 0.7 | — |
| Selling & marketing | 0.0 | 0.0 | — |
| Operating expenses | 0.0 | 0.7 | — |
| Operating income | (0.0) | (0.7) | (1.4) |
| Interest expense | 0.0 | 0.0 | — |
| Interest income | 0.0 | 5.1 | 9.6 |
| Other income / expense | 0.0 | 5.1 | — |
| Pre-tax income | (0.0) | 4.4 | 8.2 |
| Income tax | 0.0 | 0.0 | 0.0 |
| Net income | (0.0) | 4.4 | 8.2 |
| Discontinued operations | 0.0 | 0.0 | — |
| Other net income adjustments | 0.0 | 0.0 | — |
| EPS, basic (per share) | 0.00 | 0.13 | 0.24 |
| EPS, diluted (per share) | 0.00 | 0.13 | 0.24 |
| EBITDA | (0.0) | (0.7) | (1.4) |
| Depreciation & amortization | 0.0 | 0.0 | — |
| Weighted average shares (shares) | 30,293,333 | 34,693,333 | — |
| Weighted average diluted shares (shares) | 30,293,333 | 34,693,333 | — |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
